Topic: IntelliCentrics News

In a newly published white paper, IntelliCentrics presents why support from the technology sector is essential to achieving herd immunity
DALLAS (April 6, 2021) –IntelliCentrics (6819.HK), the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and BioBytes™ Visitor, serving healthcare facilities across North America, the United Kingdom, and China, releases a special white paper entitled “COVID-19 Vaccine – Impact on Healthcare.” At a high level, the paper reviews the impact of the vaccine’s distribution and the need for a new level of trust in healthcare.  

By offering free medical credentialing on the industry’s most advanced technology platform, IntelliCentrics takes a huge leap forward in its mission to make high-quality healthcare as accessible as a good cup of coffee.
DALLAS (March 29, 2021) – IntelliCentrics (6819.HK) announces a $100 million savings pledge in support of the frontline workers and the locations of care its technology platform serves. IntelliCentrics’ innovative technologies includes SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™, and BioBytes™ Visitor,

Putting patients in control of visitor management in the healthcare setting, IntelliCentrics’ BioBytes™ radically improves safety and security for all while dramatically lowering costs for all locations of care.
DALLAS (March 8, 2021) – IntelliCentrics (6819.HK), the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and now BioBytes™ Visitor, serves healthcare facilities across North America, the United Kingdom, and China, announces the creation of another industry first, BioBytes Visitor. BioBytes Visitor delivers value on two concurrent vectors by giving patients control over who can visit them when receiving care while providing locations of care (LOCs) with the ability to apply their safety and COVID-19 policies to visitors.

From the waiting room to the board room, IntelliCentrics’ technology provides healthcare facilities the control they need to ensure the safety of their visitors and communities at large.
DALLAS (February 7, 2021) – IntelliCentrics (6819.HK), a healthcare technology platform company and innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO! and BioBytes™ serving North America, the United Kingdom and China, all on an integrated, end-to-end technology platform, announces the creation of the industry’s first COVID-19 credential available to all users across its technology platform.

A single app integrating COVID-19 Plans for everywhere we gather; BioBytes™ is transforming how we care for ourselves, our family, and our community.
DALLAS (January 25, 2021) – IntelliCentrics (6819.HK), a healthcare technology platform company and innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO! and BioBytes™ serving North America, the United Kingdom and China, all on an integrated, end-to-end technology platform, announces the latest expansion of BioBytes™ innovations.
“Whether at a local restaurant, grocery store,

ACCELERATING OPEN, EARLY STAGE TECHNOLOGY COLLABORATION WITH THE GOAL OF DEMOCRATIZING ACCESS TO HIGH-QUALITY HEALTHCARE
DALLAS (November 23rd, 2020) – IntelliCentrics (6819.HK), creator of SEC³URE Ethos, SEC³URE Passport, Link & GO! and BioBytes™ serving North America, the United Kingdom and China, all on an integrated, end-to-end technology platform, announced that IntelliCentrics’ “5th Ring Advisory Board” has been created and will be led by IntelliCentrics Chief Innovation Officer (CIO) and long-term executive David Taylor.
“I was so fascinated by IntelliCentrics’ vision to improve healthcare by integrating love from family and friends with the medical sciences;

DALLAS (March 16th, 2020) – SEC³URE Link, IntelliCentrics’ latest technological innovation, delivers trust as a technology in support of the people most at risk in the war against COVID-19. SEC³URE Link accomplishes this by integrating healthcare policy with credentialing and scheduling into a single solution. The result is a trusted healthcare delivery system where all stakeholders have the information and controls needed to safely deliver care.
“Any delay may cost lives,” said Michael Sheehan, CEO of IntelliCentrics.